【Healthkoreanews】Pfizer has withdrawn its application to switch the legal status of the 50mg tablet strength of Viagra (an oral medication for the treatment of erectile dysfunction (ED)) from ‘prescription only’ to ‘non-prescription(OTC)’ in the European Union (EU).
According to Pfizer's announcement, it has decided to withdraw the application in order to fully consider comments from the EMEA’s Committee for Medicinal Products for Human Use (CHMP), recognizing that there were some concerns regarding the proposed supply of Viagra 50mg tablets without a prescription in the EU.
Pfizer believes that access to Viagra 50mg without a prescription in a pharmacy setting in the EU would provide valuable benefits to male patients suffering from ED.<헬스코리아뉴스>